Form EFFECT Cingulate Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 26, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cingulate publishes PK data for ADHD drug CTx-1301 in CNS Drugs
- Green District Files Plans for First Integrated Urban Smart City in Orlando's Historic Parramore Neighborhood
- BODY20 Expands EMS Beyond Strength Training with New 20-Minute Tone Class
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share